公开(公告)号：US20230312703A1

公开(公告)日：2023-10-05

申请号：US18128310

申请日：2023-03-30

Applicant: Janssen Biotech, Inc.

Inventor： Daphne Chan ,  Olivia Choi ,  Long-Long Gao ,  Jenny Jeyarajah ,  Shu Li ,  Katelyn Rowland ,  Vikash Sinha ,  Yanli Wang

IPC: C07K16/24 ,  A61K45/06 ,  A61P17/06 ,  A61K9/00

CPC classification number: C07K16/244 ,  A61K45/06 ,  A61P17/06 ,  A61K9/0019 ,  A61K2039/505

Abstract: A method of treating mild to moderate psoriasis in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial dose and subsequent doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.

公开(公告)号：US20210347880A1

公开(公告)日：2021-11-11

申请号：US17308302

申请日：2021-05-05

Applicant: Janssen Biotech, Inc.

Inventor： Omoniyi Adedokun ,  Daphne Chan ,  Yang Chen ,  Philippe Szapary

IPC: C07K16/24 ,  A61P1/00 ,  A61K45/06

Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.

公开(公告)号：US20230151087A1

公开(公告)日：2023-05-18

申请号：US17986374

申请日：2022-11-14

Applicant: Janssen Biotech, Inc.

Inventor： Omoniyi Adedokun ,  Daphne Chan ,  Yang Chen ,  Philippe Szapary

IPC: C07K16/24 ,  A61P37/06

CPC classification number: C07K16/244 ,  A61P37/06 ,  C07K2317/565 ,  A61K2039/545

Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.

公开(公告)号：US20210308220A1

公开(公告)日：2021-10-07

申请号：US17212424

申请日：2021-03-25

Applicant: Janssen Biotech, Inc.

Inventor： Omoniyi Adedokun ,  Daphne Chan ,  Yang Chen ,  Philippe Szapary

IPC: A61K38/17 ,  C07K16/24 ,  A61P1/00 ,  A61P37/06

Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.

公开(公告)号：US12138295B2

公开(公告)日：2024-11-12

申请号：US17212424

申请日：2021-03-25

Applicant: Janssen Biotech, Inc.

Inventor： Omoniyi Adedokun ,  Daphne Chan ,  Yang Chen ,  Philippe Szapary

IPC: A61K38/17 ,  A61K39/00 ,  A61P1/00 ,  A61P37/06 ,  C07K16/24

Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.

公开(公告)号：US20240368265A1

公开(公告)日：2024-11-07

申请号：US18765663

申请日：2024-07-08

Applicant: Janssen Biotech, Inc.

Inventor： Omoniyi Adedokun ,  Daphne Chan ,  Yang Chen ,  Philippe Szapary

IPC: C07K16/24 ,  A61K39/00 ,  A61P37/06

Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.

公开(公告)号：US20190269757A1

公开(公告)日：2019-09-05

申请号：US16291310

申请日：2019-03-04

Applicant: Janssen Biotech, Inc.

Inventor： Omoniyi Adedokun ,  Daphne Chan ,  Yang Chen ,  Philippe Szapary

IPC: A61K38/17 ,  C07K16/24 ,  A61P1/00 ,  A61P37/06

Abstract: A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.